Purchase Order 75N92023P00252
Award Date
8/15/23
Potential Completion Date
8/15/24
Potential Value
$180K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Olink Proteomics AB
Ultimate Awardee
Not listed
PSC Category
B504 - Special Studies/Analysis- Chemical/Biological
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sweden
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health's National Human Genome Research Institute awarded a $697,695 firm fixed price purchase order to Olink Proteomics AB of Uppsala, Sweden. The one-year contract calls for Olink to measure the proteomic profiles of 1,000 plasma samples across 3,072 proteins using its proprietary Olink Explore 3072 technology. Performance will take place at Olink's facilities in Uppsala and Boston. There was no set-aside designation, as the sole-source award was made directly to...
This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute to Olink Proteomics AB, a foreign-owned for-profit organization, to provide Olink Biomarker Analysis Services. The $249,250.00 contract has a performance period through May 16, 2024 and does not have a set-aside designation. Olink Proteomics specializes in multiplex protein biomarker analysis platforms and has previously supported NIH, Food and Drug...
The Department of Health and Human Services, National Institutes of Health, National Human Genome Research Institute awarded a firm fixed price purchase order contract to Olink Proteomics AB, a foreign-owned for-profit organization, to evaluate multiple proteins in plasma samples. The $247,996.10 contract has a performance period ending on May 13, 2023. No set-aside designation was used for this award. Olink Proteomics AB specializes in proprietary multiplex protein biomarker analysis...
This contract was awarded by the Department of Health and Human Services, National Institutes of Health, National Heart Lung and Blood Institute to the prime contractor Olink Proteomics AB, a foreign-owned for-profit organization. The contract is for $248,950.00 and is for the OLINK EXPLORE EXPANSION (4) requirement, which includes the provision of Olink's proprietary multiplex protein biomarker analysis technologies and platforms to support biomedical research. The contract has a firm fixed...
This is a firm fixed price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), to Olink Proteomics AB, a foreign-owned for-profit company based in Sweden. The $69,388 contract is for Olink to provide laboratory services, specifically protein biomarker analysis using their proprietary multiplex platforms, to support NICHD's biomedical research across disease areas such as cancer, cardiovascular disease,...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Olink Proteomics AB, a foreign-owned for-profit organization based in Sweden, to provide 200 samples of Olink Explore 3072 protein analysis services for $140,000. The services will be performed in Watertown, Massachusetts. This award was made under a simplified acquisition without any set-aside, and the original solicitation...
This is a $30,625.00 firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company. The contract is for Olink's EXPLORE HT proteomics analysis service, which provides high-multiplex protein biomarker discovery capabilities. Olink Proteomics has a history of providing proteomics instruments, reagents, and analysis services to...
This federal contract award to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company, was issued by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services. The $19,785.63 firm-fixed-price purchase order is for Olink assay kits to enable the agency to use their existing Olink equipment and avoid the expense of having samples analyzed by Olink. This award does not have a set-aside designation. Olink Proteomics is...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $249,250.00 firm fixed price purchase order to Olink Proteomics AB, a foreign-owned for-profit organization, for biomarker analysis services. The services include the use of Olink's proprietary multiplex protein biomarker analysis platforms and technologies to support biomedical research efforts across disease areas like cancer, cardiovascular disease, and COVID-19. The...
This is a firm fixed price purchase order for $34,902.00 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, to Olink Proteomics AB, a foreign-owned for-profit entity based in Sweden. The contract is for the delivery of Olink Proteomics' proprietary Inflammation reagent kits and Dynamic Array chips, which support multiplex protein biomarker analysis. This purchase order was awarded under simplified acquisition procedures...